Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.

Particularly for therapeutic applications in vivo, where endogenous anti-AAV antibodies frequently compromise the therapeutic efficacy of gene delivery, the latter characteristic may be significant [ 30 , 114 , 115 ].

also in 13,097 other papers